Skyscape Web Viewer : Physicians' Cancer Chemotherapy Drug Manual : Main Index

View All
Obinutuzumab Leukemia Obinutuzumab Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Lymphoma Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function
octreotide LAR
ofatumumab Ofatumumab Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
olanzapine Common Regimens for Chemotherapy-Induced Nausea and Vomiting Common Regimens for Delayed and/or Breakthrough Nausea and Vomiting:
olaparib Breast Cancer Ovarian Cancer (Epithelial) Prostate Cancer Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Olaparib Pancreatic Cancer Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function
olutasidenib Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Olutasidenib
omacetaxine mepesuccinate
Oncovin
ondansetron Common Regimens for Delayed and/or Breakthrough Nausea and Vomiting: Common Regimens for Chemotherapy-Induced Nausea and Vomiting Common Regimens for Radiation-Induced Nausea and Vomiting:
Onivyde
Opdivo
Orgovyx
OSI-774
osimertinib Osimertinib Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Lung Cancer Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function
ovarian cancer epithelial germ cell
oxaliplatin Anal Cancer Cancer of Unknown Primary Esophageal Cancer Lymphoma Pancreatic Cancer Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Testicular Cancer Biliary Tract Cancer Colorectal Cancer Hepatocellular Cancer Oxaliplatin Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
octreotide
Odomzo
omacetaxine
Oncaspar
Ontak
Opdualag
Orserdu
osteogenic sarcoma